showed a trendP < 0.001
Similarly, meta-analysis of the 2 studies comparing different insulin formulations showed a trend toward better control with insulin lispro, with a mean difference of 0.21 mmol/L in the fasting plasma glucose levels (−0.31 to −0.11, P < 0.001).